Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsResearchers describe the development of a platform to supplement existing tools of pre-clinical malaria vaccine development, by displaying linear peptides on a virus-like particle
[npj Vaccines]
6445218 {6445218:HWIMTX35} apa 50 1 160791 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-35a59696a124d3b38923c2e5870bbfaa%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22HWIMTX35%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Atcheson%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAtcheson%2C%20E.%2C%20Hill%2C%20A.%20V.%20S.%2C%20%26amp%3B%20Reyes-Sandoval%2C%20A.%20%282021%29.%20A%20VLP%20for%20validation%20of%20the%20Plasmodium%20falciparum%20circumsporozoite%20protein%20junctional%20epitope%20for%20vaccine%20development.%20%3Ci%3ENpj%20Vaccines%3C%5C%2Fi%3E%2C%20%3Ci%3E6%3C%5C%2Fi%3E%281%29%2C%201%26%23x2013%3B9.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41541-021-00302-x%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41541-021-00302-x%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DHWIMTX35%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20VLP%20for%20validation%20of%20the%20Plasmodium%20falciparum%20circumsporozoite%20protein%20junctional%20epitope%20for%20vaccine%20development%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erwan%22%2C%22lastName%22%3A%22Atcheson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%20V.%20S.%22%2C%22lastName%22%3A%22Hill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arturo%22%2C%22lastName%22%3A%22Reyes-Sandoval%22%7D%5D%2C%22abstractNote%22%3A%22Malaria%20continues%20to%20be%20a%20pressing%20global%20health%20issue%2C%20causing%20nearly%20half%20a%20million%20deaths%20per%20year.%20An%20effective%20malaria%20vaccine%20could%20radically%20improve%20our%20ability%20to%20control%20and%20eliminate%20this%20pathogen.%20The%20most%20advanced%20malaria%20vaccine%2C%20RTS%2CS%2C%20confers%20only%2030%25%20protective%20efficacy%20under%20field%20conditions%2C%20and%20hence%20the%20search%20continues%20for%20improved%20vaccines.%20New%20antigens%20and%20formulations%20are%20always%20first%20developed%20at%20a%20pre-clinical%20level.%20This%20paper%20describes%20the%20development%20of%20a%20platform%20to%20supplement%20existing%20tools%20of%20pre-clinical%20malaria%20vaccine%20development%2C%20by%20displaying%20linear%20peptides%20on%20a%20virus-like%20particle%20%28VLP%29.%20Peptides%20from%20PfCSP%2C%20particularly%20from%20outside%20the%20normal%20target%20of%20neutralizing%20antibodies%2C%20the%20central%20NANP%20repeat%20region%2C%20are%20screened%20for%20evidence%20of%20protective%20efficacy.%20One%20peptide%2C%20recently%20identified%20as%20a%20target%20of%20potent%20neutralizing%20antibodies%20and%20lying%20at%20the%20junction%20between%20the%20N-terminal%20domain%20and%20the%20central%20repeat%20region%20of%20PfCSP%2C%20is%20found%20to%20confer%20protective%20efficacy%20against%20malaria%20sporozoite%20challenge%20in%20mice%20when%20presented%20on%20the%20Q%5Cu03b2%20VLP.%20The%20platform%20is%20also%20used%20to%20explore%20the%20effects%20of%20increasing%20numbers%20of%20NANP%20unit%20repeats%2C%20and%20including%20a%20universal%20CD4%2B%20T-cell%20epitope%20from%20tetanus%20toxin%2C%20on%20immunogenicity%20and%20protective%20efficacy.%20The%20VLP-peptide%20platform%20is%20shown%20to%20be%20of%20use%20in%20screening%20malaria%20peptides%20for%20protective%20efficacy%20and%20answering%20basic%20vaccinology%20questions%20in%20a%20pre-clinical%20setting.%22%2C%22date%22%3A%222021-04-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41541-021-00302-x%22%2C%22ISSN%22%3A%222059-0105%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41541-021-00302-x%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-04-02T06%3A28%3A46Z%22%7D%7D%5D%7D
Atcheson, E., Hill, A. V. S., & Reyes-Sandoval, A. (2021). A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development. Npj Vaccines, 6(1), 1–9. https://doi.org/10.1038/s41541-021-00302-x Cite
